Derrick Randall
DERRICK RAYMOND RANDALL- MSc DEFENSE
“Identification of a Serum Biomarker for
Mucopolysaccharidosis I”
B. Sc.H., The University of British Columbia, 2003
Tuesday, April 18th, 2006, 12:30 pm, Room K0-155, BC
Children’s Hospital
Derrick Randall - MSc defense - pdf
SUPERVISORY COMMITTEE
Dr. Lorne A. Clarke, Research Supervisor (Medical
Genetics)
Dr. Jan M. Friedman (Medical Genetics)
Dr. W. Robert McMaster (Medical Genetics)
EXAMINING COMMITTEE
Chair: Dr.
Wyeth Wasserman (Medical Genetics)
Supervisory
Committee: Dr. Lorne A. Clarke, Research Supervisor (Medical
Genetics), Dr. W. Robert McMaster (Medical Genetics)
University
Examiner: Dr. Fabio Rossi (Medical Genetics)
ABSTRACT
The mucopolysaccharidoses are a clinically heterogeneous group of lysosomal storage disorders presenting with broad multi-system disease and a continuous range of phenotypes. Currently there are no objective biomarkers of MPS disease that clearly reflect disease severity or therapeutic responsiveness. Using proteomic studies in the murine MPS I model, I have identified the formation of the heparin cofactor II-thrombin (HCII-T) complex, a well-known serine protease inhibitor (serpin)-serine protease complex, as an informative biomarker for MPS I. MPS I patients showed a range of serum HCII-T concentrations from 16,300–208,600 pM, whereas the control values varied from 34.94 – 1491 pM. HCII-T complex was also elevated in plasma from MPS I patients and mice. The degree of HCII-T complex formation appears to correlate with disease severity and is responsive to therapy. In addition to its role as a biomarker, the discovery of increased serpin-serine protease complex formation provides a valuable insight into possible pathophysiological mechanisms of MPS disease.
PUBLICATIONS
Derrick
R. Randall, Graham B. Sinclair, Karen E. Colobong, and Lorne A.
Clarke,
PRESENTATIONS
Derrick R. Randall, Graham B. Sinclair, Karen E. Colobong,
and Lorne A. Clarke.
Derrick R. Randall, Graham B. Sinclair, Karen E. Colobong,
and Lorne A. Clarke.
Derrick R. Randall, Graham B. Sinclair, Karen E. Colobong,
and Lorne A. Clarke.
Derrick R. Randall, Graham B. Sinclair, Karen E. Colobong,
and Lorne A. Clarke. “Serum biomarker discovery for MPS disease: Utility of the
murine MPS I model.” American Society of Human Genetics 2005 meeting, Salt Lake
City, UT, October 25 – 29, 2005. (Poster)
Derrick R. Randall. “Proteomics in MPS disease study: The
value of an animal model.” Centre for Molecular Medicine & Therapeutics
TGIF Lecture Series, Vancouver, BC, September 30, 2005. (Oral)
Graham Sinclair, Derrick Randall, Karen Yip and Lorne A.
Clarke. “Serum prefractionation for isotope-coded affinity tag (ICAT)
proteomics and biomarker
AWARDS
Medical Genetics Graduate Entrance Scholarship
GRADUATE STUDIES
Field of
Study: Mucopolysaccharidoses, lysosomal storage disorders,
and proteomics
Courses:
MEDG 419 Human Cytogenetics Drs. C. Brown, L. Lefebvre, and
W. Robinson
MEDG 515 Mammalian Developmental Genetics Drs. M. Harris
and D. Juriloff
MEDG 520 Advanced Human Molecular Genetics Drs. A.
Brooks-Wilson, C. Brown, R. McMaster, F. Rossi, E. Simpson, and W. Wasserman
MEDG 530 Human Genetics Drs. L. Clarke, C. Conibear, M.
Harris, B. Leavitt
MEDG 535 Current Topics in Medical Genetics Research Drs. M. Harris and D. Juriloff
Derrick Randall - MSc defense - pdf

